Chargement en cours...
Treatment of Hepatitis C Virus (HCV) Genotype 1 Disease
The landscape of therapeutic options for HCV infection has dramatically changed with the approval of all-oral direct-acting antiviral (DAA) regimens. DAAs target important steps in the HCV viral life cycle, resulting in higher response rates and fewer adverse events than were afforded with interfero...
Enregistré dans:
| Publié dans: | Curr Treat Options Infect Dis |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966038/ https://ncbi.nlm.nih.gov/pubmed/29805320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40506-017-0124-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|